Stroke Treatment Guideline from AHA-ASA

Document ID: RD-137348

11/09/2020

Author: Karen L. Furie, Scott E. Kasner, Robert J. Adams, Gregory W. Albers, Ruth L. Bush


Panduan Penatalaksaan Stroke

References:

1. Johnston SC, Fayad PB, Gorelick PB, Hanley DF, Shwayder P, van Husen D, Weiskopf T. Prevalence and knowledge of transient ischemic attack among US adults. Neurology. 2003;60:1429 –1434.
2. Measuring and improving quality of care: a report from the American Heart Association/American College of Cardiology First Scientific Forum on Assessment of Healthcare Quality in Cardiovascular Disease and Stroke. Circulation. 2000;101:1483–1493.
3. Johnston SC, Gress DR, Browner WS, Sidney S. Short-term prognosis after emergency department diagnosis of TIA. JAMA. 2000;284:2901–2906.
4. Rothwell PM, Warlow CP. Timing of TIAs preceding stroke: time window for prevention is very short. Neurology. 2005;64:817– 820.
5. Easton JD, Saver JL, Albers GW, Alberts MJ, Chaturvedi S, Feldmann E, Hatsukami TS, Higashida RT, Johnston SC, Kidwell CS, Lutsep HL, Miller E, Sacco RL. Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease. Stroke. 2009;40:2276 –2293.
6. Ovbiagele B, Kidwell CS, Saver JL. Epidemiological impact in the United States of a tissue-ba

KONTEN TERKAIT

 
RD-137348
Production date: September 2020

Informasi penting terkait keamanan Alteplase (Actilyse®)

Efek samping penggunaan Actilyse® yang paling sering dijumpai adalah perdarahan. Risiko perdarahan intrakranial berada di rentang 2-7% dan mayoritas terjadi dalam 24 jam pertama pasca trombolisis. Silakan membaca Actilyse® Full Prescribing Information  terkait profil keamanan & tolerabilitas Actilyse® selengkapanya.
​​​​​​​